FIELD: medicine, pharmacy. SUBSTANCE: invention proposes using 4-chlorophenylthioacetic acid dimethylethanolammonium salt as an immunomodulating agent. Early this agent is known as an anti-hemolytic and anti-aggregative agent. EFFECT: expanded assortment of agents of claimed designation. 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODULATING AGENT | 2003 |
|
RU2245142C1 |
IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
IMMUNOMODULATING AGENT | 2003 |
|
RU2224513C1 |
IMMUNOMODULATOR | 2003 |
|
RU2252757C1 |
IMMUNOMODULATING AGENT | 2003 |
|
RU2240794C1 |
IMMUNOSUPRESSOR | 2003 |
|
RU2253448C1 |
IMMUNODEPRESSANT | 2002 |
|
RU2228178C1 |
IMMUNOMODULATOR | 2003 |
|
RU2253447C1 |
IMMUNODEPRESSANT | 2016 |
|
RU2637643C1 |
IMMUNOMODULATOR | 2003 |
|
RU2253445C1 |
Authors
Dates
2004-02-27—Published
2003-03-27—Filed